The use of psychotropic medication in patients referred to a psycho-oncology service

Antidepressant therapy in cancer patients: initiation and factors associated with treatment

“…Psychological distress and mood disorders are highly prevalent in cancer settings, and pharmacological treatment, in the form of psychotropic medicines, is commonplace in oncology practice . In our study cohort, approximately one in six antidepressant‐naive cancer patients commenced treatment with an overall initiation rate of 9.0/100 person‐years.…”

“…While there is a growing body of research investigating the prevalence of depression in cancer patients, relatively few studies have investigated the uptake or patterns of antidepressant therapy in these populations . This is despite exponential growth in antidepressant prescribing in modern medical practice, publication of evidence‐based guidelines for treatment of depression in cancer patients and use of antidepressants in the oncology setting to manage anxiety, insomnia and pain …”

Psychohematology. Attempt to Summarise

“…A high degree of resilience can help patients to adapt to their situation and to resume their everyday life [109] . The problem of MD in patients undergoing bone marrow t r a n s p l a n t a t i o n , a n d i s c l o s e l y r e l a t e d t o t h e i s s u e o f compliance [63,[110][111][112][113] . Improving the perception of pain and other subjective unbearable sensations that occur when performing such manipulations in patients (and especially in the context of comorbid depression [113] ) may violate compliance, which could result in rejection of invasive but necessary diagnostic and therapeutic procedures.…”

“…Improving the perception of pain and other subjective unbearable sensations that occur when performing such manipulations in patients (and especially in the context of comorbid depression [113] ) may violate compliance, which could result in rejection of invasive but necessary diagnostic and therapeutic procedures. Of special importance is the problem of compliance in the case of patients with schizophrenia, because in these conditions, along with interventions for diseases of the blood must have an adequate psychopharmacotherapy [111,112] .…”

Psychiatric comorbidity among terminally ill patients in general practice in the Netherlands: a comparison between patients with cancer and heart failure

“…[18][19][20] To bypass the potential problem of systematic under-reporting, this study examined prescriptions of psychotropic drugs as a proxy indicator of psychiatric comorbidity in the study of terminally ill patients. [21][22][23] However, it is possible that the significant increase in the use of psychotropic drugs in the terminal stage may also indicate the high prevalence of psychological and somatic symptoms experienced by the patients that do not fulfil the diagnosis of psychiatric disorder but warrant intervention. 24,25 To date, it is unclear if the increased incidence of psychiatric symptoms in the last phase of life is unique to cancer or related to the terminal disease stage in general.…”